Probiotic administration reduces mortality and improves intestinal epithelial homeostasis in experimental sepsis

Anesthesiology

Volumn 119, Issue 1, 2013, Pages 166-177

  Khailova, Ludmila ^a   Frank, Daniel N ^a   Dominguez, Jessica A ^a   Wischmeyer, Paul E ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; MYELOID DIFFERENTIATION FACTOR 88; PROBIOTIC AGENT; PROTEIN KINASE B; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BACTERIAL PERITONITIS; BACTERIAL STRAIN; BIFIDOBACTERIUM LONGUM; CECAL LIGATION AND PUNCTURE; CELL PROLIFERATION; COLON; CONTROLLED STUDY; DRUG EFFICACY; HOMEOSTASIS; INFLAMMATION; INTESTINE EPITHELIUM CELL; LACTOBACILLUS RHAMNOSUS; LAPAROTOMY; LIGATION; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PUNCTURE; RECEPTOR DOWN REGULATION; RISK REDUCTION; SEPSIS; SEPTIC PERITONITIS; SHAM PROCEDURE; SIGNAL TRANSDUCTION; SURVIVAL RATE;

ANIMALS; APOPTOSIS; BACTEREMIA; BIFIDOBACTERIUM; BLOTTING, WESTERN; CELL PROLIFERATION; COLON; HOMEOSTASIS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; INTESTINAL MUCOSA; LACTOBACILLUS RHAMNOSUS; MICE; ONCOGENE PROTEIN V-AKT; PERITONITIS; PROBIOTICS; PROTO-ONCOGENE PROTEINS C-AKT; REAL-TIME POLYMERASE CHAIN REACTION; RNA; SEPSIS; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84883248386     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e318291c2fc     Document Type: Article

References (67)

1. Milbrandt EB, Kersten A, Rahim MT, Dremsizov TT, Clermont G, Cooper LM, Angus DC, Linde-Zwirble WT: Growth of intensive care unit resource use and its estimated cost in Medicare. Crit Care Med 2008; 36:2504-10
2. Lukacs SL, Schoendorf KC, Schuchat A: Trends in sepsisrelated neonatal mortality in the United States, 1985-1998. Pediatr Infect Dis J 2004; 23:599-603
3. Wynn JL, Scumpia PO, Delano MJ, O'Malley KA, Ungaro R, Abouhamze A, Moldawer KL: Increased mortality and altered immunity in neonatal sepsis produced by generalized peritonitis. Shock 2007; 28:675-83
4. Herridge MS, Cheung AM, Tansey CM, Matte-Martyn A, Diaz-Granados N, Al-Saidi F, Cooper AB, Guest CB, Mazer CD, Mehta S, Stewart TE, Barr A, Cook D, Slutsky AS; Canadian Critical Care Trials Group: One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 2003; 348:683-93
5. Herridge MS, Tansey CM, Matté A, Tomlinson G, Diaz-Granados N, Cooper A, Guest CB, Mazer CD, Mehta S, Stewart TE, Kudlow P, Cook D, Slutsky AS, Cheung AM; Canadian Critical Care Trials Group: Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med 2011; 364:1293-304
6. Adams-Chapman I, Stoll BJ: Neonatal infection and longterm neurodevelopmental outcome in the preterm infant. Curr Opin Infect Dis 2006; 19:290-7
7. Singhi SC, Baranwal A: Probiotic use in the critically ill. Indian J Pediatr 2008; 75:621-7
8. Clark JA, Coopersmith CM: Intestinal crosstalk: A new paradigm for understanding the gut as the "motor" of critical illness. Shock 2007; 28:384-93
9. Hassoun HT, Kone BC, Mercer DW, Moody FG, Weisbrodt NW, Moore FA: Post-injury multiple organ failure: The role of the gut. Shock 2001; 15:1-10
10. Mainous MR, Ertel W, Chaudry IH, Deitch EA: The gut: A cytokine-generating organ in systemic inflammation? Shock 1995; 4:193-9
11. Clark JA, Gan H, Samocha AJ, Fox AC, Buchman TG, Coopersmith CM: Enterocyte-specific epidermal growth factor prevents barrier dysfunction and improves mortality in murine peritonitis. Am J Physiol Gastrointest Liver Physiol 2009; 297:G471-9
12. De-Souza DA, Greene LJ: Intestinal permeability and systemic infections in critically ill patients: Effect of glutamine. Crit Care Med 2005; 33:1125-35
13. Neal MD, Leaphart C, Levy R, Prince J, Billiar TR, Watkins S, Li J, Cetin S, Ford H, Schreiber A, Hackam DJ: Enterocyte TLR4 mediates phagocytosis and translocation of bacteria across the intestinal barrier. J Immunol 2006; 176:3070-9
14. Clark JA, Clark AT, Hotchkiss RS, Buchman TG, Coopersmith CM: Epidermal growth factor treatment decreases mortality and is associated with improved gut integrity in sepsis. Shock 2008; 30:36-42
15. Coopersmith CM, Stromberg PE, Dunne WM, Davis CG, Amiot DM II, Buchman TG, Karl IE, Hotchkiss RS: Inhibition of intestinal epithelial apoptosis and survival in a murine model of pneumonia-induced sepsis. JAMA 2002; 287:1716-21
16. Hotchkiss RS, Swanson PE, Freeman BD, Tinsley KW, Cobb JP, Matuschak GM, Buchman TG, Karl IE: Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 1999; 27:1230-51
17. Osterberg J, Ljungdahl M, Haglund U: Influence of cyclooxygenase inhibitors on gut immune cell distribution and apoptosis rate in experimental sepsis. Shock 2006; 25:147-54
18. Siempos II, Ntaidou TK, Falagas ME: Impact of the administration of probiotics on the incidence of ventilator-associated pneumonia: A meta-analysis of randomized controlled trials. Crit Care Med 2010; 38:954-62
19. Hammerman C, Bin-Nun A, Kaplan M: Germ warfare: Probiotics in defense of the premature gut. Clin Perinatol 2004; 31:489-500
20. Hojsak I, Abdović S, Szajewska H, Milosević M, Krznarić Z, Kolacek S: Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics 2010; 125:e1171-7
21. Morrow LE, Kollef MH, Casale TB: Probiotic prophylaxis of ventilator-associated pneumonia: A blinded, randomized, controlled trial. Am J Respir Crit Care Med 2010; 182:1058-64
22. Pitsouni E, Alexiou V, Saridakis V, Peppas G, Falagas ME: Does the use of probiotics/synbiotics prevent postoperative infections in patients undergoing abdominal surgery? A meta-analysis of randomized controlled trials. Eur J Clin Pharmacol 2009; 65:561-70
23. Bausserman M, Michail S: The use of Lactobacillus GG in irritable bowel syndrome in children: A double-blind randomized control trial. J Pediatr 2005; 147:197-201
24. Bin-Nun A, Bromiker R, Wilschanski M, Kaplan M, Rudensky B, Caplan M, Hammerman C: Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr 2005; 147:192-6
25. Drouault-Holowacz S, Bieuvelet S, Burckel A, Cazaubiel M, Dray X, Marteau P: A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome. Gastroenterol Clin Biol 2008; 32:147-52
26. Arvola T, Laiho K, Torkkeli S, Mykkänen H, Salminen S, Maunula L, Isolauri E: Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: A randomized study. Pediatrics 1999; 104:e64
27. Hempel S, Newberry SJ, Maher AR, Wang Z, Miles JN, Shanman R, Johnsen B, Shekelle PG: Probiotics for the prevention and treatment of antibiotic- associated diarrhea: A systematic review and meta-analysis. JAMA 2012; 307:1959-69
28. Schultz MJ: Symbiotics as a preventive measure against ventilator-associated pneumonia. Crit Care Med 2010; 38:1506-7
29. Giamarellos-Bourboulis EJ, Bengmark S, Kanellakopoulou K, Kotzampassi K: Pro-and synbiotics to control inflammation and infection in patients with multiple injuries. J Trauma 2009; 67:815-21
30. Kotzampassi K, Giamarellos-Bourboulis EJ, Voudouris A, Kazamias P, Eleftheriadis E: Benefits of a synbiotic formula (Synbiotic 2000Forte) in critically Ill trauma patients: Early results of a randomized controlled trial. World J Surg 2006; 30:1848-55
31. Shanahan F: Probiotics and inflammatory bowel disease: From fads and fantasy to facts and future. Br J Nutr 2002; 88(suppl 1):S5-9
32. Luyer MD, Buurman WA, Hadfoune M, Speelmans G, Knol J, Jacobs JA, Dejong CH, Vriesema AJ, Greve JW: Strain-specific effects of probiotics on gut barrier integrity following hemorrhagic shock. Infect Immun 2005; 73:3686-92
33. Zareie M, Johnson-Henry K, Jury J, Yang PC, Ngan BY, McKay DM, Soderholm JD, Perdue MH, Sherman PM: Probiotics prevent bacterial translocation and improve intestinal barrier function in rats following chronic psychological stress. Gut 2006; 55:1553-60
34. Khailova L, Mount Patrick SK, Arganbright KM, Halpern MD, Kinouchi T, Dvorak B: Bifidobacterium bifidum reduces apoptosis in the intestinal epithelium in necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 2010; 299:G1118-27
35. Tao Y, Drabik KA, Waypa TS, Musch MW, Alverdy JC, Schneewind O, Chang EB, Petrof EO: Soluble factors from Lactobacillus GG activate MAPKs and induce cytoprotective heat shock proteins in intestinal epithelial cells. Am J Physiol Cell Physiol 2006; 290:C1018-30
36. Yan F, Cao H, Cover TL, Whitehead R, Washington MK, Polk DB: Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 2007; 132:562-75
37. Yan F, Polk DB: Probiotic bacterium prevents cytokineinduced apoptosis in intestinal epithelial cells. J Biol Chem 2002; 277:50959-65
38. Agüero G, Villena J, Racedo S, Haro C, Alvarez S: Beneficial immunomodulatory activity of Lactobacillus casei in malnourished mice pneumonia: Effect on inflammation and coagulation. Nutrition 2006; 22:810-9
39. Arribas B, Rodríguez-Cabezas ME, Comalada M, Bailón E, Camuesco D, Olivares M, Xaus J, Zarzuelo A, Gálvez J: Evaluation of the preventative effects exerted by Lactobacillus fermentum in an experimental model of septic shock induced in mice. Br J Nutr 2009; 101:51-8
40. Matsumoto T, Ishikawa H, Tateda K, Yaeshima T, Ishibashi N, Yamaguchi K: Oral administration of Bifidobacterium longum prevents gut-derived Pseudomonas aeruginosa sepsis in mice. J Appl Microbiol 2008; 104:672-80
41. Tok D, Ilkgul O, Bengmark S, Aydede H, Erhan Y, Taneli F, Ulman C, Vatansever S, Kose C, Ok G: Pretreatment with proand synbiotics reduces peritonitis-induced acute lung injury in rats. J Trauma 2007; 62:880-5
42. Baker CC, Chaudry IH, Gaines HO, Baue AE: Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery 1983; 94:331-5
43. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR: Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA 2007; 104:13780-5
44. Frank JA, Reich CI, Sharma S, Weisbaum JS, Wilson BA, Olsen GJ: Critical evaluation of two primers commonly used for amplification of bacterial 16S rRNA genes. Appl Environ Microbiol 2008; 74:2461-70
45. Rinttilä T, Kassinen A, Malinen E, Krogius L, Palva A: Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J Appl Microbiol 2004; 97:1166-77
46. Vyas D, Robertson CM, Stromberg PE, Martin JR, Dunne WM, Houchen CW, Barrett TA, Ayala A, Perl M, Buchman TG, Coopersmith CM: Epithelial apoptosis in mechanistically distinct methods of injury in the murine small intestine. Histol Histopathol 2007; 22:623-30
47. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-54
48. Stern LE, Falcone RA Jr, Kemp CJ, Stuart LA, Erwin CR, Warner BW: Effect of massive small bowel resection on the Bax/Bcl-w ratio and enterocyte apoptosis. J Gastrointest Surg 2000; 4:93-100
49. Hajjar AM, Harowicz H, Liggitt HD, Fink PJ, Wilson CB, Skerrett SJ: An essential role for non-bone marrow-derived cells in control of Pseudomonas aeruginosa pneumonia. Am J Respir Cell Mol Biol 2005; 33:470-5
50. Alverdy JC, Chang EB: The re-emerging role of the intestinal microflora in critical illness and inflammation: Why the gut hypothesis of sepsis syndrome will not go away. J Leukoc Biol 2008; 83:461-6
51. Wang X, Andersson R, Soltesz V, Leveau P, Ihse I: Gut origin sepsis, macrophage function, and oxygen extraction associated with acute pancreatitis in the rat. World J Surg 1996; 20:299-307
52. Cleveland J, Montville TJ, Nes IF, Chikindas ML: Bacteriocins: Safe, natural antimicrobials for food preservation. Int J Food Microbiol 2001; 71:1-20
53. Lee YK, Lim CY, Teng WL, Ouwehand AC, Tuomola EM, Salminen S: Quantitative approach in the study of adhesion of lactic acid bacteria to intestinal cells and their competition with enterobacteria. Appl Environ Microbiol 2000; 66:3692-7
54. Alberda C, Gramlich L, Meddings J, Field C, McCargar L, Kutsogiannis D, Fedorak R, Madsen K: Effects of probiotic therapy in critically ill patients: A randomized, double-blind, placebo-controlled trial. Am J Clin Nutr 2007; 85:816-23
55. Dani C, Biadaioli R, Bertini G, Martelli E, Rubaltelli FF: Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate 2002; 82:103-8
56. McNaught CE, Woodcock NP, Anderson AD, MacFie J: A prospective randomised trial of probiotics in critically ill patients. Clin Nutr 2005; 24:211-9
57. Honeycutt TC, El Khashab M, Wardrop RM III, McNeal-Trice K, Honeycutt AL, Christy CG, Mistry K, Harris BD, Meliones JN, Kocis KC: Probiotic administration and the incidence of nosocomial infection in pediatric intensive care: A randomized placebo-controlled trial. Pediatr Crit Care Med 2007; 8:452-8; quiz 464
58. Alverdy JC, Laughlin RS, Wu L: Influence of the critically ill state on host-pathogen interactions within the intestine: Gutderived sepsis redefined. Crit Care Med 2003; 31:598-607
59. Akira S, Takeda K: Toll-like receptor signalling. Nat Rev Immunol 2004; 4:499-511
60. Williams DL, Ha T, Li C, Kalbfleisch JH, Schweitzer J, Vogt W, Browder IW: Modulation of tissue Toll-like receptor 2 and 4 during the early phases of polymicrobial sepsis correlates with mortality. Crit Care Med 2003; 31:1808-18
61. Edelman DA, Jiang Y, Tyburski J, Wilson RF, Steffes C: Tolllike receptor-4 message is up-regulated in lipopolysaccharide-exposed rat lung pericytes. J Surg Res 2006; 134:22-7
62. Yu M, Shao D, Liu J, Zhu J, Zhang Z, Xu J: Effects of ketamine on levels of cytokines, NF-kappaB and TLRs in rat intestine during CLP-induced sepsis. Int Immunopharmacol 2007; 7:1076-82
63. Xiao SD, Zhang DZ, Lu H, Jiang SH, Liu HY, Wang GS, Xu GM, Zhang ZB, Lin GJ, Wang GL: Multicenter, randomized, controlled trial of heat-killed Lactobacillus acidophilus LB in patients with chronic diarrhea. Adv Ther 2003; 20:253-60
64. Hempel S NS, Ruelaz A, Wang Z, Miles JNV, Suttorp MJ, Johnsen B, Shanman R, Slusser W, Fu N, Smith A, Roth E, Polak J, Motala A, Perry T, Shekelle PG: Safety of Probiotics to Reduce Risk and Prevent or Treat Disease. Evidence Report/Technology Assessment No. 200. AHRQ Publication No. 11-E007 April 2011
65. De Groote MA, Frank DN, Dowell E, Glode MP, Pace NR: Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome. Pediatr Infect Dis J 2005; 24:278-80
66. Besselink MG, van Santvoort HC, Buskens E, Boermeester MA, van Goor H, Timmerman HM, Nieuwenhuijs VB, Bollen TL, van Ramshorst B, Witteman BJ, Rosman C, Ploeg RJ, Brink MA, Schaapherder AF, Dejong CH, Wahab PJ, van Laarhoven CJ, van der Harst E, van Eijck CH, Cuesta MA, Akkermans LM, Gooszen HG; Dutch Acute Pancreatitis Study Group: Probiotic prophylaxis in predicted severe acute pancreatitis: A randomised, double-blind, placebo-controlled trial. Lancet 2008; 371:651-9
67. Morrow LE, Gogineni V, Malesker MA: Synbiotics and probiotics in the critically ill after the PROPATRIA trial. Curr Opin Clin Nutr Metab Care 2012; 15:147-50